Effect of antibiotic-loaded hydrophilic stent in the prevention of bacterial adherence: a study of the charge, discharge, and recharge concept using ciprofloxacin
Jw. Leung et al., Effect of antibiotic-loaded hydrophilic stent in the prevention of bacterial adherence: a study of the charge, discharge, and recharge concept using ciprofloxacin, GASTROIN EN, 53(4), 2001, pp. 431-437
Background: Ciprofloxacin prophylaxis significantly prolonged stent patency
in cats, but human studies produced conflicting results, possibly due to v
arying drug levels in bile. The uptake (charge) and release (discharge) of
ciprofloxacin from a hydrophilic stent (HS) in an antibiotic solution and t
he effect of a ciprofloxacin-loaded stent (CHS) in inhibiting Escherichia c
oil adherence were tested. The adjuvant effect of ciprofloxacin perfusion (
recharge) in the inhibition of E coil adherence was also tested.
Methods: Uptake: segments of HS were immersed in 5 mi of ciprofloxacin solu
tions for 24 hours. Ciprofloxacin remaining in solution was measured to det
ermine the uptake by the HS, Release: CHS were placed in 5 mt water for 24
hours, and released ciprofloxacin was measured. CHS were placed on culture
plates with E coli and incubated; diameters of inhibited zones were measure
d. CHS 0.5 cm in length were incubated in separate 5 mt E coil suspension (
10(7) colony forming units [CFU]/mL) in 2% ox bile for 4 hours. E coil adhe
red on CHS were measured and compared with control HS, An E coil (10(6) CFU
/mL) suspension was perfused through a modified Robbins device (MRD)-contai
ning CHS. Stents were removed at regular intervals and processed to determi
ne the adherence of E coil; non-loaded us served as controls. The experimen
t was repeated by using CHS together with perfusion of ciprofloxacin soluti
on (0.3 mug/mL) into the MRD for up to 7 days; normal saline solution was u
sed as a control in a second MRD, Stents were removed daily to determine th
e adherence of E coli.
Results: Uptake and release of ciprofloxacin by HS and CHS, respectively, w
ere related to concentration of ciprofloxacin. Between 50% to 90% of the dr
ug was released in 24 hours. Zonal inhibition of E coil growth was proporti
onal to the concentration of ciprofloxacin on the CHS, There was an initial
10-fold reduction in attached E coli on CHS compared with controls, but th
is effect diminished after 24 hours. With ciprofloxacin perfusion, there wa
s a 100-fold reduction in adhered E coil on CHS, although there was no chan
ge in E coil concentration in bile.
Conclusions: There was a free exchange (uptake and release) of ciprofloxaci
n along a concentration gradient between the antibiotic solution and us. CH
S reduced the number of adhered E coil, but the effect was short-lived. Per
fusion of ciprofloxacin offers an adjuvant benefit by enhancing inhibition
of E coil adherence on CHS.